Advisor Group’s Loxo Oncology, Inc LOXO Stock Holding History

Advisor Group’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-505	Closed	-$71K	–	5469
2018 Q4	$71K	Buy	505 +222	+78%	+$33.7K	﹤0.01%	2939
2018 Q3	$49K	Buy	283 +68	+32%	+$11.4K	﹤0.01%	3315
2018 Q2	$37K	Sell	215 -50	-19%	-$7.51K	﹤0.01%	3336
2018 Q1	$31K	Buy	+265	New	+$28.2K	﹤0.01%	3412

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Advisor Group's LOXO Position: Q1 2019 in Review

Advisor Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 505 shares — an estimated $71K sold.

Advisor Group first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $71K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Advisor Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Advisor Group sold 505 Loxo Oncology, Inc shares in Q1 2019, an estimated $71K.
Advisor Group first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
Advisor Group's Loxo Oncology, Inc position peaked at $71K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.